ATPC vs. BRTX, MRAI, MGRX, OPGN, KDLY, OTRK, BGLC, SSY, DHAC, and VSEE
Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include BioRestorative Therapies (BRTX), Marpai (MRAI), Mangoceuticals (MGRX), OpGen (OPGN), Kindly MD (KDLY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry.
Agape ATP vs.
Agape ATP (NASDAQ:ATPC) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.
In the previous week, BioRestorative Therapies had 2 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for BioRestorative Therapies and 0 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.00 equaled BioRestorative Therapies'average media sentiment score.
Agape ATP has a beta of 2.16, meaning that its stock price is 116% more volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 62.62, meaning that its stock price is 6,162% more volatile than the S&P 500.
Agape ATP has a net margin of -194.09% compared to BioRestorative Therapies' net margin of -2,697.08%. Agape ATP's return on equity of -74.71% beat BioRestorative Therapies' return on equity.
BioRestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 902.79%. Given BioRestorative Therapies' stronger consensus rating and higher possible upside, analysts plainly believe BioRestorative Therapies is more favorable than Agape ATP.
0.0% of Agape ATP shares are owned by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are owned by institutional investors. 9.7% of Agape ATP shares are owned by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Agape ATP has higher revenue and earnings than BioRestorative Therapies. Agape ATP is trading at a lower price-to-earnings ratio than BioRestorative Therapies, indicating that it is currently the more affordable of the two stocks.
BioRestorative Therapies received 2 more outperform votes than Agape ATP when rated by MarketBeat users.
Summary
BioRestorative Therapies beats Agape ATP on 10 of the 16 factors compared between the two stocks.
Get Agape ATP News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Agape ATP Competitors List
Related Companies and Tools
This page (NASDAQ:ATPC) was last updated on 2/22/2025 by MarketBeat.com Staff
